In BRAF mutant melanoma cells, exosomal transfer of proteins to the neighboring cells activates the PI3K/AKT signaling pathway and induces resistance to BRAF kinase inhibitors in patients harboring the BRAF V600E activating alteration. Here, BRAF is linked to melanoma.